HKEX:1877

Shanghai Junshi Biosciences Co., Ltd. Stock Insider Trading

Hong Kong Stock Exchange > Healthcare > Biotechnology

Open Broker Account

HK$12.82

+1.06 (+9.01%)

At Close: May 02, 2024

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, and infectious diseases in the People's Republic of China. The company offers JS001, a recombinant humanized anti-PD-1 monoclonal antibody under the trade name of TUOYI for the indication of melanoma, mucosal melanoma, soft tissue ... 1877.HK Profile

Golden Star

Ticker	Date	Change	Price
HRB	Apr 29	1.00%	$47.23
LYG	Apr 29	0.391%	$2.56
ORA	Apr 29	1.95%	$64.48
ETSY	Apr 26	3.43%	$67.43
DHT	Apr 24	0.98%	$11.28
LPLA	Apr 19	1.10%	$262.59
MLI	Apr 19	7.29%	$52.28
PFLT	Apr 18	1.33%	$11.25
DOOR	Apr 18	0.94%	$131.39
OCSL	Apr 17	0.360%	$19.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Shanghai Junshi Biosciences Co., Ltd. Stock Insider Trading

About Shanghai Junshi Biosciences Co., Ltd.

Golden Star

Top Fintech Company